Step by Stepa HemeOncBuddy patient portal

Enzalutamide

Illustration: Enzalutamide

Say it: en-za-LOO-ta-mide · Brand names: Xtandi

Enzalutamide is a hormone pill that blocks testosterone from reaching prostate cancer cells.

What it is

Prostate cancer cells have tiny docking spots, called androgen receptors, that testosterone attaches to. Enzalutamide blocks these docking spots so the cancer cells cannot use testosterone to grow. It is often used along with a shot or pill that lowers testosterone.

Often used for

How you get it

Enzalutamide is a capsule or tablet you take by mouth once a day. You can take it with or without food. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Enzalutamide?
Enzalutamide is a hormone pill that blocks testosterone from reaching prostate cancer cells. Brand names: Xtandi.
What is Enzalutamide used for?
prostate cancer that has spread; prostate cancer that keeps growing despite low testosterone; prostate cancer with a rising PSA (prostate specific antigen) after surgery or radiation.
How is Enzalutamide given?
Enzalutamide is a capsule or tablet you take by mouth once a day. You can take it with or without food. Your schedule may be different.
What are the common side effects of Enzalutamide?
Feeling tired or weak. Hot flashes. Back, joint or muscle pain. Less appetite. Constipation or diarrhea. High blood pressure. Dizziness or falls.
When should I call my care team while taking Enzalutamide?
A seizure, or a short time when you black out; Severe headache, confusion, vision changes, or a seizure, which can be signs of a rare brain swelling; Chest pain or pressure, or pain in the arm, neck or jaw; Swelling of the face, lips, tongue or throat, or trouble breathing; A fall, or bone pain after a fall.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.